Banville Law's goal is simple and direct: justice for patients harmed by dangerous pharmaceutical products.
Our experienced attorneys have turned their full attention to the developing Invokana litigation, and would gladly accept referrals from another attorney.
Our team is currently investigating the claims of patients who believe that an SGLT2 inhibitor type 2 diabetes drug may have caused ketoacidosis, kidney impairment or renal failure.
Banville Law's attorneys are currently licensed to practice in New York State.
If you are interested in referring a case to Banville Law, or would like more information on our attorneys' qualifications, call 877-671-6480 or fill out our contact form.